Seeking Alpha

SciClone Pharmaceuticals (SCLN) -14.1% premarket after announcing that a special committee found...

SciClone Pharmaceuticals (SCLN) -14.1% premarket after announcing that a special committee found evidence of sales and marketing activities that might violate the Foreign Corrupt Practices Act, leading its president of international sales to resign. The drugmaker yesterday reported a decline in Q1 profit.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|